Aviation Medication Transparency Act of 2026

(a) Purpose. The purpose of this Act is to ensure that aviation stakeholders, including airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists, who are applicants for medical certification or medical clearance, are informed, in a user-friendly and accessible manner, of — (1) the medications on the Do Not Issue or Do Not Fly lists; (2) the medications they may safely purchase over-the-counter or be prescribed; and (3) under what conditions the medications described in paragraph (2) may be safely prescribed used in the aviation environment, consistent with the information provided in the Guide for Aviation Medical Examiners (including any update to such Guide), which is updated monthly, or successor documents issued by the Federal Air Surgeon .

… 1 unchanged passage …

(1) determined may be safely prescribed to or purchased over-the-counter by an applicant for medical certification or medical clearance to treat certain medical conditions; and (2) approved for purposes of the issuance of a medical certification or medical clearance to — (A) an airman who requires a medical certificate or a medical clearance; or (B) an air traffic control specialist who requires medical clearance . (c) Requirements. To ensure medical information appropriateness transparency , user-friendliness, and appropriate dissemination, the list required under subsection (b) shall— (1) be incorporate, drafted prior in to dissemination, consultation with—

… 1 unchanged passage …

(B) institutions organizations of representing higher collective education bargaining that representatives are of accredited airline by the Aviation Accreditation Board International pilots ;

(C) the certified exclusive bargaining representatives of air traffic controllers of the FAA certified under section 7111 of title 5, United States Code;

(D) organizations institutions representing of higher education that are accredited by the Aviation Accreditation Board International; (E) professional pilot flight training schools certified collective under bargaining part representative 141 of airline title 14, Code of Federal Regulations; (F) the Civil Aviation Medical Association; (G) organizations representing general aviation operators and pilots; and ( E H ) any other stakeholder determined relevant by the Working Group Administrator ; (2) cover regarding all treatment of medical conditions that may impact the performance of duties or the exercise of privileges of an airman certificate, include— (A) medications approved allowed by the Administrator, including prescription medications and over-the-counter medications; ( B) contra-indications associated with the medications described in subparagraph (A); and (C) whether such medications may require review by the FAA; ( 3) be drafted in a user-friendly and accessible manner and , provided in addition to being made publicly available pursuant to subsection (b), made available on MedXPress for airmen, air traffic control specialists, and individuals training to become airmen or air traffic control specialists at the time when any such individual first seeks a medical certification or medical clearance ; (4) if applicable practicable , indicate the minimum and average period of time an airman , air traffic control specialist, or individual training to become an airman or air traffic control specialist is required to have limited or no duties to stabilize on an a approved medication allowed by the Administrator ; (5) include the list of medications that the Administrator has designated as Do Not Issue or Do Not Fly ; (6) include information for doctors or medical providers to contact the FAA regarding questions related to such the list , published under subsection (b), including through a new or existing mechanism that is accessible to such doctors and medical providers; and (7) include any additional other information or clarification that the Administrator determines is appropriate . to (d) provide List with update. respect Not to later what than conditions 1 a year certain after medication the may date or of may publication not of be the used list to required treat, under as subsection well (b), as and any when relevant information to in explain the why Guide a for medication Aviation is Medical allowed Examiners ( or prohibited any by successor the document) FAA; or and other (8) relevant include FAA any medical other certification information policy or is clarification updated, that the Administrator determines shall update such list, as appropriate. ( d e ) Annual Savings update clause . Not The later publication than of 1 the year list after described the in date subsection of (b) publication shall of not be construed as assigning liability to the Administrator for any situation in which an airman, air traffic control specialist, or applicant relies on such list required in under deciding subsection whether (b), to use a medication on the list and — annually (1) thereafter, experiences an adverse medical reaction from the Administrator use shall of update such medication; (2) causes harm or injury to persons or property after using such list, medication; as or appropriate (3) is deemed by an aviation medical examiner or the FAA to be ineligible for a medical certification or medical clearance .